Knowing Is Not Enough, We Must Apply: SGLT2 Inhibitors as Foundational Therapy for HFrEF

Drs Petrie and Zieroth use multiple cases to discuss the role of SGLT2 inhibitors in the management of HFrEF. Credit available for this activity expires: 9/15/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/958550?src=mkm_podcast_addon_958550